DOI: 10.1055/s-00000030

Der Klinikarzt

References

Sands BE, Chen J, Feagan BG. et al
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study.

Gastroenterology 2017;
153: 77-86 e76

Download Bibliographical Data

Access:
Access: